Moderna signs mRNA access deals with S.Korea's universities

The US biotech and pharmaceutical company Moderna on Friday announced signings of contracts with the academic-industry cooperation foundations of Ko...

Moderna to stay ahead in mRNA technology: CSO Melissa Moore

CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...

Korea approves export of Samsung Biologics-made Moderna vaccine

South Korea approved exports of Moderna Inc.’s COVID-19 vaccine produced by Samsung Biologics Co. in a move that will help the country’s...

Jay Y. Lee meets Verizon CEO and Moderna co-founder

Samsung Electronics Co. Vice Chairman Jay Y. Lee has met with biopharmaceutical conglomerate Moderna’s co-founder and telecommunications g...

Samsung Biologics-made Moderna vaccine available to Koreans this week

Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be avai...

Korean govt to spend $1.9 billion to become world’s leading vaccine maker

The South Korean government will invest 2.2 trillion won ($1.9 billion) by 2025 to become a top five vaccine producer in the world. President Moon J...

COVID treatment deals drive Samsung Bio’s record quarterly earnings

South Korea’s Samsung Biologics Co. posted its highest quarterly revenue and operating profit, thanks largely to a number of long-term manufac...

Samsung Biologics to make Moderna’s mRNA vaccine from Q3

Samsung Biologics Co. will be manufacturing the US company Moderna’s COVID-19 vaccine (mRNA-1273) from the second half of this year in Korea. ...

Moderna deal shows Korea’s prowess as global hub for biopharma CMO

South Korea is emerging as a global hub for the contract manufacturing of biopharmaceuticals following its latest deal to procure COVID-19 vaccines ...